BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

AutoImmune Incorporated

AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical productsfor the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. At the start of 1999 the Company was conducting clinical trials for the following products: Colloral(R), for the treatment of rheumatoid arthritis, and AI 502, for the treatment of chronic transplant rejection. A third product, AI 401, for the treatment of Type 1 diabetes, is in Phase II clinical trials supported by Eli Lilly and Company ("Lilly") and the National Institutes of Health ("NIH"). The Company believes, based on preclinical and clinical data, that its proprietary approach to therapy can induce tissue-specific immunosuppression without toxicity or significant side effects. Additional clinical and commercial advantages of this approach include the ability to administer products orally (the preferred method of treating chronic diseases) and the potential for application to a variety of inflammatory diseases and conditions.


Contact Details:
1199 Madia Street
Pasadena
CA
91103
United States of America
Tel:626 792 1235
Fax:626 792 1236
Email:
WWW:

www.autoimmuneinc.com/




Loading...

Recent Publications by AutoImmune Incorporated:

Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
Rheumatoid arthritis (RA) progresses more rapidly in some patients than in...
2nd January, 2009
Center for Autoimmune Disease Research (CREA), School of Medicine, Rosario J Autoimmun. 2008 Dec 29.
DOI Direct Link
Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship.
Smell has traditionally been considered a less important sense when...
23rd December, 2008
Universidade Federal Fluminense, Niteroi, RJ, Brazil; Center for Clin Immunol. 2008 Dec 17.
DOI Direct Link
Antiphospholipid syndrome.
ABSTRACT: Antiphospholipid syndrome is diagnosed when arterial or venous...
19th December, 2008
Department of Autoimmune Diseases, Institut Clinic de Medicina i Arthritis Res Ther. 2008 Dec 15;10(6):230.
DOI Direct Link
Infections and the Antiphospholipid Syndrome.
Currently, the origin of autoimmune diseases is considered to be...
18th December, 2008
Systemic Autoimmune Diseases Research Unit, HGR#36, CMN Manuel Avila Clin Rev Allergy Immunol. 2008 Dec 17.
DOI Direct Link
Ronald A. Asherson-"In Memoriam"
Currently, the origin of autoimmune diseases is considered to be...
18th December, 2008
Department of Medicine 'B' and Center for Autoimmune Diseases, Chaim Sheba Clin Rev Allergy Immunol. 2008 Dec 17.
DOI Direct Link

View more AutoImmune Incorporated research publications.

BioNews Results for AutoImmune Incorporated:

Steroid Trial Helps in Differential Diagnosis of Autoimmune Pancreatitis
Medscape:  Jan 3 2009 2:27AM Matching: autoimmune
Involvement of the Apoptotic Mechanism in Pemphigus Foliaceus Autoimmune Injury of the Skin
MDLinx:  Jan 2 2009 12:09AM Matching: autoimmune
The Incidence of Autoimmune Thyroid Disease: A Systematic Review of the Literature
Medscape:  Dec 31 2008 4:49PM Matching: autoimmune
Cutting edge: Autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-α in lup
MDLinx:  Dec 31 2008 9:27AM Matching: autoimmune
VLST Corporation And Novo Nordisk Announce Collaboration Agreement To Develop Therapeutics For Autoimmune And
Medical News Today:  Dec 24 2008 9:34AM Matching: autoimmune
Promote your company here: BioNewsCast - Press Release Distribution

View more AutoImmune Incorporated news.

AutoImmune Incorporated Patents:

US Patent No.Title
6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin
5807993 HP-8 autoantigen
5788968 Methods and compositions for suppressing allograft rejection in mammals
5783188 Method of treating rheumatoid arthritis with type collagen peptide fragments containing repeating sequences
5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin

View more AutoImmune Incorporated patents.

AutoImmune Incorporated (AIMM) Financial information Links from Barchart

AIMM Quote from from Barchart.com
AIMM Chart from from Barchart.com
AIMM Profile from from Barchart.com
AIMM Opinion from from Barchart.com

View more AutoImmune Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 221 individuals from AutoImmune Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 622 times since April 2007, the link to the organisation's website has been followed 117 times

Recent Search Terms used to find this page: autoimmune | autoimmune increase 2008 | AI-502 peptide | autoimmune diseases | autoimmunity drug discovery meeting 2008 | t | treatment hospital infection April 2008 | autoimmune contact home company about search | autoimmune pharmaceuticals AI 401 | autoimmune incorporated | .

Search for more companies in Pasadena

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for AutoImmune Incorporated

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.